Besides, CD38 and ZAP70 expression, which can be determined by flow cytometry, were found to correlate with IGHV status, disease progression and survival of patients with CLL [3, 4]. The gene discussed is ZAP70; the disease is B-cell chronic lymphocytic leukemia.